Moran Meiron

Moran Meiron is an experienced leader in the field of immunotherapy and pharmaceutical research, currently serving as Senior Director of Immunotherapy at Orgenesis Inc. since October 2020. Prior roles include Vice President of Research at Cell Cure Neurosciences, where Moran contributed to cell therapies for retinal and neural degenerative diseases, and Vice President of Research and Development at Raziel Therapeutics, focusing on fat reduction therapies. At Cellect Bio, Moran led R&D efforts for hematopoietic cell products aimed at treating graft-versus-host disease and held directorial positions overseeing pre-clinical research at UroGene and Nephera. Beginning a research career as Research Director at Pluristem Therapeutics, Moran has developed expertise in conducting pre-clinical studies and innovative research. Educational credentials include a Ph.D. in Immunology and a Master’s in Regulation of Gene Expression from Technion - Israel Institute of Technology, alongside a Bachelor’s degree from The Hebrew University of Jerusalem.